GGrantIndex
← Leaderboards

George R Beck

Emory University

$2,971,982
Attributed
$3,463,851
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $680.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,463,851 · 6
VA$0 · 3

By mechanism

R01$2,222,574 · 2
R21$776,263 · 2
K22$310,014 · 1
R03$155,000 · 1
I01$0 · 2
IS1$0 · 1

Top collaborators

Most similar at Emory University

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsElementsOsteoporosisPublishingBoneSerumIn VivoFractureBaseSignal TransductionIn VitroTissuesBone MassBone LossBone MetabolismNutritionalBone DensityOperative Surgical ProceduresInorganic PhosphateCell PhysiologyBone DiseasesDietIntakeHospitalization

Grant awards (27)

Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2025 · VA · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2024 · VA · contact PI
Novel strategies to target lung cancer metastasis to bone$179,252
R21 · FY2023 · CA · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2023 · VA · contact PI
Novel strategies to target lung cancer metastasis to bone$219,491
R21 · FY2022 · CA · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2022 · VA · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2021 · VA · contact PI
ShEEP Request For A Pre-Clinical In-Vivo X-Ray Micro Computed-Tomography Scanner$0
IS1 · FY2021 · VA · contact PI
Targeted nanoparticles for biomedical applications$171,600
R21 · FY2020 · AR · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2020 · VA · contact PI
Targeted nanoparticles for biomedical applications$205,920
R21 · FY2019 · AR · contact PI
Contribution of Phosphate to Inflammatory Bone Loss$0
I01 · FY2019 · VA · contact PI
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass$0
I01 · FY2017 · VA · contact PI
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass$0
I01 · FY2016 · VA · contact PI
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass$0
I01 · FY2015 · VA · contact PI
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass$0
I01 · FY2014 · VA · contact PI
Inorganic phosphate regulated proliferation, transformation and tumorigenesis$293,258
R01 · FY2013 · CA · contact PI
Inorganic phosphate regulated proliferation, transformation and tumorigenesis$311,976
R01 · FY2012 · CA · contact PI
Inorganic phosphate regulated proliferation, transformation and tumorigenesis$311,976
R01 · FY2011 · CA · contact PI
Inorganic phosphate regulated proliferation, transformation and tumorigenesis$321,625
R01 · FY2010 · CA · contact PI
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio$281,651
R01 · FY2010 · AR
Dietary Inorganic Phosphate as a Target for Nutritional intervention in Cancer$77,500
R03 · FY2010 · CA · contact PI
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio$327,555
R01 · FY2009 · AR
Dietary Inorganic Phosphate as a Target for Nutritional intervention in Cancer$77,500
R03 · FY2009 · CA · contact PI
Biological Actions and Cellular Targeting of Nanoparticles for Medical Applicatio$374,533
R01 · FY2008 · AR
ROLE OF P270 IN DIFFERENTIATION AND TUMORIGENESIS$155,007
K22 · FY2006 · CA · contact PI
ROLE OF P270 IN DIFFERENTIATION AND TUMORIGENESIS$155,007
K22 · FY2005 · CA